A Supreme Court ruling this week on gender and sexuality “conversion therapy” could narrow the authority of state medical ...

Astroline launched Angel Numbers Explorer to decode 111, 222 as prompts for career/love shifts. Free on app/web, pairs ...

The involving Centessa Pharmaceuticals marks a notable step in expanding therapeutic reach into neuroscience. This move ...

More than a dozen major mental health and medical organizations have renounced conversion therapy as ineffective and harmful.

Readers discuss the justices’ decision on gay conversion therapy. Also: An immigrant’s story; a list of Jews at Penn?

The Supreme Court has ruled that Colorado's law banning conversion therapy "regulates speech based on viewpoint." ...

The FDA has granted Fast Track, Orphan Drug, Priority Review, and Rare Pediatric Disease designations to apitegromab for the ...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A ...

With an end-of-week green light from the FDA, Rocket Pharmaceuticals has officially broken into commercial orbit.  | Rocket ...

Expands retina network through EyeSouth physician integration strategy; Strengthens specialty care presence across ...

Detailed price information for Relmada Therapeutics Inc (RLMD-Q) from The Globe and Mail including charting and trades.

Compass Pathways (NASDAQ:CMPS) executives outlined plans for a potential U.S. regulatory filing and commercial launch preparation for its investigational psilocybin therapy, COMP360, during a recent ...